Clomifene
- Generic Name
- Clomifene
- Brand Names
- Clomid
- Drug Type
- Small Molecule
- Chemical Formula
- C26H28ClNO
- CAS Number
- 911-45-5
- Unique Ingredient Identifier
- 1HRS458QU2
- Background
A triphenyl ethylene stilbene derivative which is an estrogen agonist or antagonist depending on the target tissue.
- Indication
Used mainly in female infertility due to anovulation (e.g. due to polycystic ovary syndrome) to induce ovulation.
- Associated Conditions
- Ovulatory Dysfunction
- Associated Therapies
- -
Evaluation of a Long Versus Short Clomid Protocol for Controlled Ovarian Stimulation
- First Posted Date
- 2024-11-22
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 60
- Registration Number
- NCT06701071
- Locations
- 🇺🇸
HRC Fertility, Pasadena, California, United States
Clomiphene Citrate in Infertile Men With Idiopathic Oligoasthenozoospermia
- First Posted Date
- 2024-08-21
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Shakeela Ishrat
- Target Recruit Count
- 50
- Registration Number
- NCT06564961
- Locations
- 🇧🇩
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Use of Clomiphene Citrate as an Inhibitor of Ovulation in an Oocyte Cryopreservation Cycle
- Conditions
- First Posted Date
- 2023-05-19
- Last Posted Date
- 2023-05-19
- Lead Sponsor
- Neil Chappell
- Target Recruit Count
- 10
- Registration Number
- NCT05866068
- Locations
- 🇺🇸
Womans Hospital, Baton Rouge, Louisiana, United States
Efficacy of Pentoxifylline and Alpha Lipoic Acid in PCOS Resistant to Clomiphene Citrate
- First Posted Date
- 2022-02-09
- Last Posted Date
- 2023-07-20
- Lead Sponsor
- Ain Shams University
- Target Recruit Count
- 120
- Registration Number
- NCT05231980
- Locations
- 🇪🇬
College of Pharmacy Teaching Hospital Ainshams University, Cairo, Egypt
🇪🇬Medical Center of Infertility, Banī Suwayf, Egypt
🇪🇬Misr University For Sciences and Technology Teaching Hospital, Giza, Egypt
Randomized Controlled Trial of Combined Letrozole and Clomid (CLC II) Versus Letrozole Alone for Women With Anovulation
- Conditions
- Interventions
- First Posted Date
- 2022-01-25
- Last Posted Date
- 2023-12-08
- Lead Sponsor
- Rachel Mejia
- Target Recruit Count
- 189
- Registration Number
- NCT05206448
- Locations
- 🇺🇸
University of Iowa Hospitals & Clinics- West Des Moines Clinic, West Des Moines, Iowa, United States
🇺🇸University of Wisconsin, Madison, Wisconsin, United States
🇺🇸University of Iowa Hospitals & Clinics - Davenport Clinic, Davenport, Iowa, United States
Vitamin D Supplementation and Improvement of PCOS Therapy and IVF Outcomes in Infertile Saudi Women
- First Posted Date
- 2021-11-04
- Last Posted Date
- 2021-11-04
- Lead Sponsor
- Umm Al-Qura University
- Target Recruit Count
- 700
- Registration Number
- NCT05106712
Sex Hormone Supplementation and Rotator Cuff Repair: A Preliminary Randomized Trial
- Conditions
- Interventions
- First Posted Date
- 2021-06-30
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 58
- Registration Number
- NCT04944836
- Locations
- 🇺🇸
University of Utah, Salt Lake City, Utah, United States
Effect of Vitamin D Oral Supplementation in Poly Csytic Ovarian Women Resistant to Clomiphene Citrate
- Conditions
- Interventions
- First Posted Date
- 2021-06-08
- Last Posted Date
- 2021-06-08
- Lead Sponsor
- rana alaaeldin aly ibrahim nasr
- Target Recruit Count
- 100
- Registration Number
- NCT04916925
Parameters Declaring PCO Infertile Patients Either Sensitive or Resistant to Different Doses of Clomiphene Citrate.
- Conditions
- Interventions
- First Posted Date
- 2021-05-14
- Last Posted Date
- 2022-02-16
- Lead Sponsor
- Ain Shams Maternity Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT04887402
- Locations
- 🇪🇬
Ain Shams University, Cairo, Egypt
Myo-inositol Versus Clomiphene Citrate in PCOS
- Conditions
- Interventions
- First Posted Date
- 2020-03-13
- Last Posted Date
- 2022-12-21
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 12
- Registration Number
- NCT04306692
- Locations
- 🇧🇪
University Hospital, Ghent, Belgium
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.